Selling by month
Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.
Disclosed planOne dollar scale for every month; the tallest bar is labeled
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 2 of the 13 calendar months from Oct 2025 to Oct 2026: Jan 2026 and Feb 2026.
- Largest single sale: $201K (8,015 shares) of Enliven Therapeutics, Inc. on Jan 8, 2026. Filing
- Last sale before this period: Oct 18, 2024.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| Enliven Therapeutics, Inc. (ELVN) | Director | Feb 27, 2023 | Feb 19, 2026 |
Recent filings
The last 4 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- Feb 17, 2026, Enliven Therapeutics, Inc.: sold 1,230 shares for $32K, under a disclosed plan (some held indirectly). 1 filing: 1
- Jan 20, 2026, Enliven Therapeutics, Inc.: sold 1,230 shares for $33K, under a disclosed plan (some held indirectly). 1 filing: 1
- Jan 9, 2026, Enliven Therapeutics, Inc.: sold 4,285 shares for $107K, under a disclosed plan (some held indirectly). 1 filing: 1
- Jan 8, 2026, Enliven Therapeutics, Inc.: sold 9,635 shares for $241K, under a disclosed plan (some held indirectly). 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.